Kinetics of radium-223 and its effects on survival, proliferation and DNA damage in lymph-node and bone metastatic prostate cancer cell lines

References

• Abou DS, Ulmert D, Doucet M, Hobbs RF, Riddle RC, Thorek DLJ. 2016. Whole-body and microenvironmental localization of radium-223 in naïve and mouse models of prostate cancer metastasis. JNCIJ. 108(5):djv380.
   PubMed Web of Science ®Google Scholar
• Aprile C, Persico MG, Lodola L, Buroni FE. 2016. Radium-223 and metastatic castration-resistant prostate cancer: all that glitters is not gold. World J Radiol. 8(10):816–818.
   PubMed Web of Science ®Google Scholar
• Armstrong AJ, Gupta S, Healy P, Kemeny G, Leith B, Zalutsky MR, Spritzer C, Davies C, Rothwell C, Ware K, et al. 2019. Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer. PLOS One. 14(5):e0216934.
   PubMed Web of Science ®Google Scholar
• Azqueta A, Collins AR. 2011. The comet assay: a sensitive and quantitative method for analysis of DNA damage. In: Meyers RA, editor. Encyclopedia of Analytical Chemistry. Chichester, UK: John Wiley & Sons, Ltd.
   Google Scholar
• Bartek J, Falck J, Lukas J. 2001. Chk2 kinase-a busy messenger. Nat Rev Mol Cell Biol. 2(12):877–886.
   PubMed Web of Science ®Google Scholar
• Benjamin RS, Wagner MJ, Livingston JA, Ravi V, Patel SR. 2015. Chemotherapy for Bone Sarcomas in Adults: The MD Anderson Experience. In: American Society of Clinical Oncology Educational Book. Vol. 35; p. 656–660.
   Google Scholar
• Body J-J, Casimiro S, Costa L. 2015. Targeting bone metastases in prostate cancer: improving clinical outcome. Nat Rev Urol. 12(6):340–356.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Brito AF, Ribeiro M, Abrantes AM, Mamede AC, Laranjo M, Casalta-Lopes JE, Gonçalves AC, Sarmento-Ribeiro AB, Tralhão JG, Botelho MF. 2016. New approach for treatment of primary liver tumors: the role of quercetin. Nutr Cancer. 68(2):250–266.
   PubMed Web of Science ®Google Scholar
• Casalta-Lopes J, Abrantes AM, Laranjo M, Rio J, Gonçalves AC, Oliveiros B, Sarmento-Ribeiro AB, Botelho MF. 2011. Efflux pumps modulation in colorectal adenocarcinoma cell lines: the role of nuclear medicine. JCT. 02(03):408–417.
   Google Scholar
• Casarin S, Dondossola E. 2020. An agent-based model of prostate cancer bone metastasis progression and response to Radium223. BMC Cancer. 20(1):605.
   PubMed Web of Science ®Google Scholar
• Cunningham D, You Z. 2015. In vitro and in vivo model systems used in prostate cancer research. J Biol Methods. 2(1):e17.
   PubMedGoogle Scholar
• Du Y, Carrio I, De Vincentis G, Fanti S, Ilhan H, Mommsen C, Nitzsche E, Sundram F, Vogel W, Oyen W, et al. 2017. Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 44(10):1671–1678.
   PubMed Web of Science ®Google Scholar
• Elgqvist J, Timmermand OV, Larsson E, Strand S-E. 2016. Radiosensitivity of prostate cancer cell lines for irradiation from beta particle-emitting radionuclide 177Lu compared to alpha particles and gamma rays. Anticancer Res. 36(1):103–109.
   PubMed Web of Science ®Google Scholar
• Harrison MR, Wong TZ, Armstrong AJ, George DJ. 2013. Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease. Cancer Manag Res. 5:1–14.
   PubMedGoogle Scholar
• Horoszewicz JS, Leong SS, Kawinski E, Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, et al. 1983. LNCaP model of human prostatic carcinoma LNCaP model of human prostatic carcinoma. ICANCER Res. 43:1809–1818.
   PubMed Web of Science ®Google Scholar
• Kwee SA, Lim J, Coel MN. 2017. Soft tissue response on 18F-fluorocholine PET/CT in metastatic castrate-resistant prostate cancer treated with 223Ra-dichloride: a possible abscopal effect? Clin Nucl Med. 42(11):868–871.
   PubMed Web of Science ®Google Scholar
• Maffioli L, Florimonte L, Costa DC, Castanheira JC, Grana C, Luster M, Bodei L, Chinol M. 2015. New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer. Q J Nucl Med Mol Imaging. 59(4):420–438.
   PubMed Web of Science ®Google Scholar
• Maier P, Hartmann L, Wenz F, Herskind C. 2016. Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization. Int J Mol Sci. 17(1):102.
   PubMed Web of Science ®Google Scholar
• Mamede AC, Abrantes AM, Pires AS, Tavares SD, Serra ME, Maia JM, Botelho MF. 2012. Radiolabelling of ascorbic acid: a new clue to clarify its action as an anticancer agent? Curr Radiopharm. 5(2):106–112.
   PubMedGoogle Scholar
• Mamede AC, Guerra S, Laranjo M, Carvalho MJ, Oliveira RC, Gonçalves AC, Alves R, Prado Castro L, Sarmento-Ribeiro AB, Moura P, et al. 2015. Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma. Med Oncol. 32(12):257.
   PubMed Web of Science ®Google Scholar
• Mamede AC, Guerra S, Laranjo M, Santos K, Carvalho MJ, Carvalheiro T, Moura P, Paiva A, Abrantes AM, Maia CJ, et al. 2016. Oxidative stress, DNA, cell cycle/cell cycle associated proteins and multidrug resistance proteins: targets of human amniotic membrane in hepatocellular carcinoma. Pathol Oncol Res. 22(4):689–697.
   PubMed Web of Science ®Google Scholar
• Manda G, Nechifor MT, Neagu T. 2009. Reactive oxygen species, cancer and anti-cancer therapies. Curr Chem Biol. 3(1):342–366.
   Google Scholar
• Marques IA, Neves AR, Abrantes AM, Pires AS, Tavares-da-Silva E, Figueiredo A, Botelho MF. 2018. Targeted alpha therapy using radium-223: from physics to biological effects. Cancer Treat Rev. 68(January):47–54.
   PubMedGoogle Scholar
• Matafome P, Santos-Silva D, Crisóstomo J, Rodrigues T, Rodrigues L, Sena CM, Pereira P, Seiça R. 2012. Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity. Arch Physiol Biochem. 118(2):58–68.
   PubMed Web of Science ®Google Scholar
• McParland BJ. 2010. Nuclear medicine radiation dosimetry. United Kingdom: Springer.
   Google Scholar
• Mendes F, Domingues C, Schugk S, Abrantes AM, Gonçalves AC, Casalta-Lopes J, Sales T, Teixo R, Silva R, Estrela J. 2016. Single shot irradiation and molecular effects on a diffuse large B cell lymphoma cell line. J Cancer Res Treat. 4(1):9–16.
   Google Scholar
• Mladenov E, Li F, Zhang L, Klammer H, Iliakis G. 2018. Intercellular communication of DNA damage and oxidative status underpin bystander effects. Int J Radiat Biol. 0(0):1–24.
   Google Scholar
• Moreira HMR, Guerra Liberal FDC, O'Sullivan JM, McMahon SJ, Prise KM. 2019. Mechanistic modeling of radium-223 treatment of bone metastases. Int J Radiat Oncol Biol Phys. 103(5):1221–1230.
   PubMed Web of Science ®Google Scholar
• Morgan SC. 2019. Radium-223 in metastatic castration-resistant prostate cancer: clinical development and use in contemporary practice. J Med Imaging Radiat Sci. S26–S30:1–5.
   PubMed Web of Science ®Google Scholar
• Neto C, Oliveira MC, Gano L, Marques F, Thiemann T, Santos I. 2012. Novel estradiol based metal complexes of Tc-99m. J Inorg Biochem. 111:1–9.
   PubMed Web of Science ®Google Scholar
• Nilsson S. 2016. Radionuclide therapies in prostate cancer: integrating radium-223 in the treatment of patients with metastatic castration-resistant prostate cancer. Curr Oncol Rep. 18(2):14.
   PubMed Web of Science ®Google Scholar
• Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, et al. 2013. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 369(3):213–223.
   PubMed Web of Science ®Google Scholar
• Pereira C, Coelho R, Grácio D, Dias C, Silva M, Peixoto A, Lopes P, Costa C, Teixeira JP, Macedo G, et al. 2016. DNA damage and oxidative DNA damage in inflammatory bowel disease. ECCOJC. 10(11):1316–1323.
   Web of Science ®Google Scholar
• Pires AS, Marques CR, Encarnação JC, Abrantes AM, Mamede AC, Laranjo M, Gonçalves AC, Sarmento-Ribeiro AB, Botelho MF. 2016. Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile. Eur J Cell Biol. 95(6–7):208–218.
   PubMed Web of Science ®Google Scholar
• Poeppel TD, Handkiewicz-Junak D, Andreeff M, Becherer A, Bockisch A, Fricke E, Geworski L, Heinzel A, Krause BJ, Krause T, et al. 2018. EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer. Eur J Nucl Med Mol Imaging. 45(5):824–845.
   PubMed Web of Science ®Google Scholar
• Poon DMC, Wong KCW. 2017. Lymph Node Response in a Patient With Metastatic Castration-resistant Prostate Cancer Treated With Radium-223.Clin Genitourin Cancer. 16(2):e397–e401.
   Google Scholar
• Rodrigues T, Matafome P, Seiça R. 2013. Methylglyoxal further impairs adipose tissue metabolism after partial decrease of blood supply. Arch Physiol Biochem. 119(5):209–218.
   PubMed Web of Science ®Google Scholar
• Suominen MI, Fagerlund KM, Rissanen JP, Konkol YM, Morko JP, Peng Z, Alhoniemi EJ, Laine SK, Corey E, Mumberg D, et al. 2017. Radium-223 inhibits osseous prostate cancer growth by dual targeting of cancer cells and bone microenvironment in mouse models. Clin Cancer Res. 23(15):4335–4346.
   PubMed Web of Science ®Google Scholar
• Suominen MI, Rissanen JP, Käkönen R, Fagerlund KM, Alhoniemi E, Mumberg D, Ziegelbauer K, Halleen JM, Käkönen S-M, Scholz A. 2013. Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis. JNCI J Natl Cancer Inst. 105(12):908–916.
   Web of Science ®Google Scholar
• Tai S, Sun Y, Squires JM, Zhang H, Oh WK, Liang CZ, Huang J. 2011. PC3 is a cell line characteristic of prostatic small cell carcinoma. Prostate. 71(15):1668–1679.
   PubMed Web of Science ®Google Scholar
• Taprogge J, Murray I, Gear J, Chittenden SJ, Parker CC, Flux GD. 2019. Compartmental model for 223Ra-dichloride in patients with metastatic bone disease from castration-resistant prostate cancer. Int J Radiat Oncol. 105(4):884–892.
   PubMed Web of Science ®Google Scholar
• Tavares-Da-Silva E, Pereira E, Pires AS, Neves AR, Braz-Guilherme C, Marques IA, Abrantes AM, Gonçalves AC, Caramelo F, Silva-Teixeira R, et al. 2021. Cold atmospheric plasma, a novel approach against bladder cancer, with higher sensitivity for the high-grade cell line. Biology. 10(1):1–19.
   Google Scholar
• Verma V, Lin SH. 2016. Implications of the bystander and abscopal effects of radiation therapy. Clin Cancer Res. 22(19):4763–4765.
   PubMed Web of Science ®Google Scholar
• Waterman DP, Haber JE, Smolka MB. 2020. Checkpoint responses to DNA double-strand breaks. Annu Rev Biochem. 89(Ddc):103–133.
   PubMedGoogle Scholar
• Widel M. 2016. Radiation induced bystander effect: from in vitro studies to clinical application. IJMPCERO. 05(01):1–17.
   Google Scholar
• Wilson JM, Parker C. 2016. The safety and efficacy of radium-223 dichloride for the treatment of advanced prostate cancer. Expert Rev Anticancer Ther. 16(9):911–918.
   PubMed Web of Science ®Google Scholar
• Zannini L, Delia D, Buscemi G. 2014. CHK2 kinase in the DNA damage response and beyond. J Mol Cell Biol. 6(6):442–457.
   PubMed Web of Science ®Google Scholar